ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 186 out of 761

$428K Total Retail Price of All Prescriptions

Rank: 182 out of 761

577 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 7,254 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 339 310 1 3
AMLODIPINE BESYLATE 329 298 2 6
OMEPRAZOLE 281 239 3 4
SIMVASTATIN 267 232 4 2
LOVASTATIN 236 207 5 17
LOSARTAN POTASSIUM 219 200 6 13
LISINOPRIL 218 186 7 1
METOPROLOL SUCCINATE 208 186 8 16
WARFARIN SODIUM 193 189 9 9
HYDROCHLOROTHIAZIDE 180 151 10 11
ALENDRONATE SODIUM 169 157 11 21
ATORVASTATIN CALCIUM 167 153 12 12
HYDROCODONE-ACETAMINOPHEN 165 143 S3 13 5
CITALOPRAM HBR 163 153 14 19
FUROSEMIDE 141 135 15 7
LOSARTAN-HYDROCHLOROTHIAZIDE 128 128 16 65
METFORMIN HCL 124 104 17 10
GABAPENTIN 108 92 18 15
TRAZODONE HCL 100 87 19 23
PRAVASTATIN SODIUM 94 90 20 20
ATENOLOL 89 89 21 8
ESCITALOPRAM OXALATE 84 67 22 102
TRAMADOL HCL 79 55 23 34
DONEPEZIL HCL 79 79 23 33
POTASSIUM CHLORIDE 78 78 25 18
ZOLPIDEM TARTRATE 77 67 26 22
DICLOFENAC SODIUM 75 67 27 142
SERTRALINE HCL 70 62 28 25
TRIAMCINOLONE ACETONIDE 69 68 29 84
DIOVAN 68 66 30 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 50 31 35
FLUTICASONE PROPIONATE 64 62 32 29
PAROXETINE HCL 63 58 33 47
CRESTOR 61 50 34 36
PANTOPRAZOLE SODIUM 59 57 35 40
BENICAR 58 57 36 81
NAMENDA 55 43 37 59
CYCLOBENZAPRINE HCL 55 34 R 37 51
ROPINIROLE HCL 51 51 39 95
BYSTOLIC 50 50 40 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.